British Generic Manufacturers Association (BGMA)

Patients suffering with cancer and severe mental illness are being hit by drug shortages, costing the NHS £180 million in half a year, according a report published by The Times. Read more


The BGMA has welcomed the publication by the NICE of an implementation pack to support the introduction of biosimilar versions of Infliximab. Read more


The British Generic Manufacturers Association (BGMA) will stage the next meeting of its Quality Forum – in conjunction with the MHRA - on Tuesday, February 24th. Read more



British Generics Manufacturers Association

Usage of generic medicines in England and Wales increased to more than three-quarters of all NHS prescriptions in 2013 according to the latest figures supplied by the HSCIC Read more